1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow fasudil: new trials by email Literature Review of fasudil trials Research Report on fasudil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer Fasudil hydrochloride and PD1 inhibitor combined with androgen deprivation therapy, Placebo combined with androgen deprivation therapy, radical prostatectomy - Prostate CA | Phase 2 / Phase 3 | Recruiting | baotai Liang | 83 | 2025-02-16 | 2025-11-18 |
| Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients injection bevacizumab, injection Combined Bevacizumab and Fasudil - Retinal Vein Occlusion | Phase 2 / Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 36 | 2018-01-01 | 2018-01-05 |
| A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon Fasudil - Raynaud, Scleroderma | Phase 3 | Completed | Johns Hopkins University | 17 | 2007-04-01 | 2014-11-04 |
Raynaud Disease (1) · Retinal Vein Occlusion (1) · Scleroderma, Diffuse (1)
Johns Hopkins University (1) · Shahid Beheshti University of Medical Sciences (1) · baotai Liang (1)
China (1) · Iran (1) · United States (1)